TET, Pharmasset Settle Spat Over Gene Test Patent

Law360, New York (August 14, 2009, 5:18 PM EDT) -- TET Systems Holding GmbH & Co. KG and Pharmasset Inc., which develops treatments for viral infections, have reached a deal in TET Systems' infringement suit over a patent related to technology that controls gene expression and can be used to test new drug compounds.

Germany-based TET Systems filed a stipulated motion for dismissal of all claims, counterclaims and defenses Thursday in the U.S. District Court for the District of New Jersey, saying that both parties had agreed to dismiss the case with prejudice and pay their...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.